Targets for the action of phytoestrogens in breast cancer - Focus on isoflavones and resveratrol

被引：4
作者：
Rice S. [1 ]
Whitehead S.A. [1 ]
机构：
[1] Division of Biomedical Sciences, St. George's University of London, London SW17 0RE, Cranmer Terrace
来源：
Current Breast Cancer Reports | 2014年 / 6卷 / 2期
关键词：
Apoptosis; Breast cancer; Cell cycle; Epigenetics; Estrogen receptors; Estrogen synthesis; Isoflavones; Phytoestrogens; Resveratrol; Signalling pathways;
D O I：
10.1007/s12609-014-0141-4
中图分类号：
学科分类号：
摘要：
Experimental evidence reveals that phytoestrogens have many targets through which they inhibit growth of breast cancer cells. These targets include cyclins, inhibitors of cyclin-dependent kinases (p21/p27), the tumour-suppressor gene p53, and pro-apoptotic and anti-apoptotic genes including Bax and Blc-2. This review covers the experimental evidence for mechanisms through which isoflavones and resveratrol may inhibit the growth of breast cancer cells, including the action of phytoestrogens on estrogen receptors and the epigenome. Although there is much evidence revealing that phytoestrogens can inhibit or stimulate these targets involved in inhibiting the growth of breast cancer cells, there is a large discrepancy between the high-μmol L-1 doses required to observe such anti-tumorigenic effects, and the blood concentrations of unbound free" phytoestrogens that would be achieved by dietary intake. It is suggested that more experiments investigating low-dose mixtures of phytoestrogens and chronic exposure to phytoestrogens - a closer model of dietary intake - are required to substantiate claims that phytoestrogens can protect against breast cancer. © Her Majesty the Queen in Right of United Kingdom 2014."
引用
收藏
页码：88 / 95
页数：7
相关论文
共 75 条
  • [1] Magee P.J., Rowland I., Soy products in the management of breast cancer, Curr Opin Clin Nutr Metab Care, 13, pp. 586-591, (2012)
  • [2] Miller P.E., Synder D.C., Phytochemicals and cancer risk: A review of the epidemiological evidence, Nutr Clin Pract, 27, pp. 599-612, (2012)
  • [3] Hilakivi-Clarke L., Andrade J.E., Helferich W., Is soy consumption good or bad for the breast?, J Nutr, 140, (2010)
  • [4] Mense S.M., Hei T.K., Ganju R.K., Bhat H.K., Phytoestrogens and breast cancer prevention: Possible mechanisms of action, Environmental Health Perspectives, 116, 4, pp. 426-433, (2008)
  • [5] Rice S., Whitehead S.A., Phytoestrogens and breast cancer-promoters or protectors?, Endocr Relat Cancer, 13, pp. 995-1015, (2006)
  • [6] Jenkins S., Betancourt A.M., Wang J., Et al., Endocrine-active chemicals in mammary cancer causation and prevention, J Steroid Biochem Mol Biol, 129, pp. 191-200, (2012)
  • [7] Liu X., Suzuki N., Santosh Laxmi Y.R., Et al., Anti-breast cancer potential of daidzein in rodents, Life Sci, 91, pp. 415-419, (2012)
  • [8] Helferich W.G., Andrade J.E., Hoagland M.S., Phytoestrogens and breast cancer: A complex story, Inflammopharmacol, 16, pp. 219-226, (2008)
  • [9] Tobin N.P., Bergh J., Analysis of cyclin D1 in breast cancer: A call to arms, Curr Breast Cancer Rep, 4, pp. 171-173, (2012)
  • [10] Velasco-Velazquez M.A., Li Z., Casimiro M., Loro E., Homsi N., Pestell R.G., Examining the role of cyclin D1 in breast cancer, Future Oncol, 7, pp. 753-765, (2011)
12345678